| Company Name |
Bafna Pharmaceuticals Ltd |
| Face Value |
10 |
| BSE Code |
532989 |
| Year End |
202603 |
| Full Year |
| Equity (Rs.Cr.) |
23.66 |
| B.V. Rs. |
40.60 |
| Sales Rs. Cr. |
150.62 |
| NP Rs. Cr. |
11.10 |
| NP Var% |
74.00 |
| Div% |
0.00 |
| CPS Rs. |
7.30 |
| EPS Rs. |
4.70 |
| Traded Value(Rs.Lakhs) |
6.42 |
| 52 Week High |
487.00 |
| 52 Week Low |
95.00 |
| Price BSE |
477.00 |
| Price NSE |
473.00 |
| Market Capital(Rs. Cr.) |
1,128.41 |
| P/C Ratio |
65.70 |
| P/E Ratio |
101.70 |
| Price Vs.BV |
11.75 |
| Year End |
202606 |
| Sales Rs. Cr. |
26.58 |
| NP Rs. Cr. |
0.08 |
| NP Var % |
-98.00 |
| Year End |
202606 |
| Sales |
143.45 |
| OPM |
3.81 |
| NP |
0.75 |
| NP Var% |
-22.65 |
| EPS |
3.29 |
| PE |
144.98 |
|
|